It is essential to emphasize that tirzepatide does not replace thyroid hormone replacement therapy, does not reduce thyroid antibody levels, and does not modify the autoimmune process in Hashimoto's disease
For additional inquiries, please contact the corresponding author.
For example, the FDA-approved obesity dose for semaglutide is a 16-week step-up to a maintenance of 1.7 or 2.4 mg weekly
Migliaccio & Rathod LLP is investigating the Triquetra GLP-Activate supplement
Additionally, GLP-1 RAs exhibit neuroprotective and anti-inflammatory effects, increase Akt dephosphorylation, decrease proinflammatory factors such as TNF-, elevate neurotrophic factors like BDNF, reduce oxidative stress and microglial activation, and enhance gut-brain axis function and gut microbiota stability [176]
There is also research into the benefit of GLP-1RAs for the liver